Correlation Between Shanghai Rongtai and Yili Chuanning

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Shanghai Rongtai and Yili Chuanning at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Shanghai Rongtai and Yili Chuanning into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Shanghai Rongtai Health and Yili Chuanning Biotechnology, you can compare the effects of market volatilities on Shanghai Rongtai and Yili Chuanning and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Shanghai Rongtai with a short position of Yili Chuanning. Check out your portfolio center. Please also check ongoing floating volatility patterns of Shanghai Rongtai and Yili Chuanning.

Diversification Opportunities for Shanghai Rongtai and Yili Chuanning

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Shanghai and Yili is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Shanghai Rongtai Health and Yili Chuanning Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Yili Chuanning Biote and Shanghai Rongtai is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Shanghai Rongtai Health are associated (or correlated) with Yili Chuanning. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Yili Chuanning Biote has no effect on the direction of Shanghai Rongtai i.e., Shanghai Rongtai and Yili Chuanning go up and down completely randomly.

Pair Corralation between Shanghai Rongtai and Yili Chuanning

Assuming the 90 days trading horizon Shanghai Rongtai Health is expected to generate 1.16 times more return on investment than Yili Chuanning. However, Shanghai Rongtai is 1.16 times more volatile than Yili Chuanning Biotechnology. It trades about 0.2 of its potential returns per unit of risk. Yili Chuanning Biotechnology is currently generating about 0.03 per unit of risk. If you would invest  1,474  in Shanghai Rongtai Health on December 25, 2024 and sell it today you would earn a total of  476.00  from holding Shanghai Rongtai Health or generate 32.29% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Shanghai Rongtai Health  vs.  Yili Chuanning Biotechnology

 Performance 
       Timeline  
Shanghai Rongtai Health 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai sustained solid returns over the last few months and may actually be approaching a breakup point.
Yili Chuanning Biote 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Yili Chuanning Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Yili Chuanning is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Shanghai Rongtai and Yili Chuanning Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Shanghai Rongtai and Yili Chuanning

The main advantage of trading using opposite Shanghai Rongtai and Yili Chuanning positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Shanghai Rongtai position performs unexpectedly, Yili Chuanning can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Yili Chuanning will offset losses from the drop in Yili Chuanning's long position.
The idea behind Shanghai Rongtai Health and Yili Chuanning Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance